Tag: Pharmacology Leadership Award

Mridul Guleria | Pharmacology | Best Researcher Award

Published on by World Science Awards

Best Researcher Award

Mridul Guleria — Guru Nanak Dev University

Mridul Guleria
Affiliation Guru Nanak Dev University
Country India
Scopus ID 59174404600
Documents 14
Citations 84
h-index 4
Subject Area Pharmacology
Event World Science Awards
ORCID 0009-0008-5898-8134

Mridul Guleria is a researcher affiliated with Guru Nanak Dev University, India, whose documented scholarly profile is associated with the field of pharmacology. The available bibliometric record identifies 14 documents, 84 citations, and an h-index of 4 in Scopus. [1] These indicators provide a concise quantitative view of the researcher’s indexed scholarly output and citation visibility.

This academic recognition profile presents the researcher’s research background, contributions, publication record, research impact, and suitability for consideration for the Best Researcher Award associated with the World Science Awards. The assessment is framed using the supplied bibliographic information and publicly identifiable researcher records rather than unsupported claims of distinction.

Abstract

Mridul Guleria is affiliated with Guru Nanak Dev University and works within the subject area of pharmacology. The researcher’s indexed profile records 14 documents, 84 citations, and an h-index of 4. [1] The profile is additionally associated with an ORCID identifier, providing a persistent scholarly identity record. [2] On the basis of the supplied academic indicators, the Best Researcher Award profile highlights scholarly productivity, citation-based visibility, subject-area relevance, and participation in research activities within pharmacology.

Keywords

Mridul Guleria; Best Researcher Award; pharmacology; pharmaceutical research; Guru Nanak Dev University; research impact; scholarly publications; citation analysis; Scopus; ORCID; World Science Awards.

Introduction

Pharmacology is a multidisciplinary area concerned with the study of drugs, their biological effects, mechanisms of action, therapeutic applications, and interactions with living systems. Research in this field contributes to the broader development and evaluation of pharmacological knowledge and can intersect with pharmaceutical sciences, biomedical research, toxicology, and related disciplines.

Within an academic recognition framework, researcher evaluation may consider several dimensions, including research productivity, publication activity, citation performance, subject relevance, originality, scholarly contribution, and broader research influence. Bibliometric databases such as Scopus can provide quantitative indicators for assessing indexed research output, while ORCID provides a persistent identifier that helps distinguish researchers and connect scholarly works with their authors. [1] [2]

Research Profile

The supplied research profile identifies Mridul Guleria as being affiliated with Guru Nanak Dev University in India and specializing in pharmacology.

These figures should be interpreted as a snapshot of the indexed research record and may change as databases update publication and citation information. [1]

Research Contributions

Mridul Guleria’s documented research specialization is pharmacology. The available record supports recognition of research activity within this subject area, while the supplied bibliometric indicators provide evidence of an established indexed publication and citation record. [1]

For academic evaluation purposes, the contribution profile can be considered across the following dimensions:

  • Subject-area engagement: Research activity is associated with pharmacology, a field relevant to drug research and biomedical science.
  • Scholarly productivity: Fourteen documents are recorded in the supplied Scopus profile.
  • Citation visibility: The supplied profile records 84 citations, indicating that indexed publications have received measurable scholarly referencing.
  • Research continuity: The presence of multiple indexed documents provides evidence of continuing scholarly publication activity.
  • Researcher identification: The association of Scopus and ORCID identifiers supports clearer attribution of scholarly work to the researcher. [1] [2]

Publications

The supplied Scopus record indicates 14 indexed documents associated with Mridul Guleria. [1] The available input does not provide a complete publication bibliography, individual article titles, journal names, publication dates, citation distributions, or DOI identifiers. Accordingly, no specific publication titles or DOI values are attributed here without bibliographic verification.

For a complete publication assessment, the Scopus author record and the researcher’s ORCID profile can be consulted to identify publications, author associations, and persistent scholarly records. [1] [2]

Research Impact

The supplied Scopus indicators show 84 citations across 14 documents and an h-index of 4. [1] These measures provide quantitative evidence of citation activity and scholarly visibility within the indexed research literature.

Citation counts and h-index values are useful indicators but should not be interpreted independently of publication context, career stage, discipline, authorship patterns, journal characteristics, or the nature of individual contributions. A balanced assessment of research impact therefore benefits from combining bibliometric information with qualitative evaluation of research originality, methodological quality, relevance, collaboration, and contribution to the field.

The presence of an ORCID identifier further supports persistent researcher identification and can facilitate the reliable association of scholarly outputs with the appropriate researcher. [2]

Award Suitability

The Best Researcher Award profile for Mridul Guleria is supported by the supplied evidence of academic affiliation, subject-area specialization, indexed publication activity, and citation performance. The World Science Awards provides the event context for this recognition. [3]

Based on the available information, relevant evaluation dimensions include:

  • Academic relevance: The researcher’s specialization in pharmacology aligns with a recognized scientific and biomedical research domain.
  • Publication record: Fourteen Scopus-indexed documents demonstrate measurable scholarly productivity. [1]
  • Citation performance: Eighty-four citations provide an observable indicator of scholarly attention to the indexed research output. [1]
  • h-index: An h-index of 4 provides an additional quantitative measure of citation distribution across the researcher’s indexed publications. [1]
  • Researcher identity: The availability of both Scopus and ORCID identifiers supports transparent scholarly attribution. [1] [2]

Taken together, these documented indicators provide a reasonable academic basis for consideration under a Best Researcher Award framework. Final award decisions, however, should be based on the official evaluation methodology, verified publication records, research quality, originality, and other criteria established by the awarding organization. [3]

Conclusion

Mridul Guleria is an India-based researcher affiliated with Guru Nanak Dev University whose documented research area is pharmacology. The supplied scholarly profile records 14 documents, 84 citations, and an h-index of 4 in Scopus, alongside an ORCID identifier that provides a persistent researcher identity. [1] [2]

The available evidence demonstrates measurable research productivity and citation visibility and provides a documented foundation for consideration for the Best Researcher Award at the World Science Awards. [3] Any final recognition should be determined through independent verification and the formal assessment criteria of the awarding body.

References

  1. Elsevier. (n.d.). Scopus author details: Mridul Guleria, Author ID 59174404600. Scopus.
    https://www.scopus.com/pages/authors/59174404600
  2. ORCID. (n.d.). ORCID record: Mridul Guleria, ORCID iD 0009-0008-5898-8134. ORCID.
    https://orcid.org/0009-0008-5898-8134
  3. World Science Awards. (n.d.). World Science Awards.
    https://worldscienceawards.com/

Mohammad Seyedabadi | Pharmacology | Best Researcher Award

Published on by World Science Awards

Best Researcher Award

Mohammad Seyedabadi, Mazandaran University of Medical Sciences
Mohammad Seyedabadi
Affiliation Mazandaran University of Medical Sciences
Country Iran
Scopus ID 24460920400
Documents 86
Citations 2,110
h-index 25
Subject Area Pharmacology
Event World Science Awards
ORCID 0000-0003-0044-8270

Mohammad Seyedabadi is a researcher affiliated with Mazandaran University of Medical Sciences in Iran, with a documented research specialization in pharmacology. The academic recognition presented in this article is the Best Researcher Award associated with the World Science Awards. The supplied research profile records 86 documents, 2,110 citations, and an h-index of 25. These bibliometric indicators provide a quantitative overview of the documented research record and are presented as profile information rather than as independent measures of scientific quality. Pharmacology encompasses the study of drugs, their mechanisms of action, therapeutic effects, adverse effects, and interactions with biological systems. [1][2]

Abstract

This article presents an academic recognition profile for Mohammad SEYEDABADI of Mazandaran University of Medical Sciences, Iran, in connection with the Best Researcher Award under the World Science Awards. The documented research subject is pharmacology, a biomedical discipline concerned with the properties, mechanisms, therapeutic applications, and safety of drugs and other bioactive substances. [1][2] The supplied bibliometric record identifies 86 documents, 2,110 citations, and an h-index of 25. These indicators suggest a substantial indexed research record within the supplied profile, while their interpretation should account for publication history, disciplinary citation practices, collaboration patterns, and the characteristics of individual publications. The award suitability discussion therefore considers the documented research specialization, publication volume, citation activity, and overall bibliometric profile without treating these measures as substitutes for qualitative assessment.

Keywords

  • Pharmacology
  • Drug discovery
  • Pharmacological research
  • Therapeutics
  • Pharmacodynamics
  • Pharmacokinetics
  • Biomedical science
  • Research impact

Introduction

Pharmacology is a central biomedical discipline that examines how chemical substances interact with living systems. It includes the study of drug mechanisms, pharmacodynamics, pharmacokinetics, therapeutic efficacy, adverse effects, and interactions. [1][2] Pharmacological research provides a scientific basis for understanding the actions of medicines and for supporting the development and evaluation of therapeutic interventions.

Modern pharmacology is closely connected with molecular biology, physiology, biochemistry, toxicology, medicinal chemistry, and clinical medicine. Research may range from investigations of molecular targets and signaling pathways to experimental evaluation of candidate compounds and clinical studies of therapeutic responses. The integration of these disciplines has contributed to the development of more selective treatments and improved understanding of drug response variability. [2][3]

Within this scientific context, Mohammad SEYEDABADI is identified in the supplied profile as a pharmacology researcher affiliated with Mazandaran University of Medical Sciences. The reported record of 86 documents, 2,110 citations, and an h-index of 25 provides a quantitative description of the indexed research profile. Further conclusions regarding specific scientific discoveries or therapeutic applications require examination of the underlying publications and verified research outputs.

Research Profile

Mohammad SEYEDABADI is affiliated with Mazandaran University of Medical Sciences in Iran. The supplied subject classification is pharmacology, placing the profile within the broader biomedical and pharmaceutical sciences. The reported combination of publication output and citation activity provides a bibliometric overview of the researcher’s indexed scholarly record. An h-index of 25 indicates that, within the supplied record, at least 25 publications have received at least 25 citations each, subject to the accuracy and coverage of the underlying database record. Bibliometric indicators should nevertheless be interpreted in their disciplinary and temporal context.

Research Contributions

The documented specialization of Mohammad SEYEDABADI is pharmacology. As a broad research field, pharmacology contributes to the scientific understanding of how therapeutic agents interact with biological targets and how those interactions influence physiological and pathological processes. [1][2] Pharmacological investigations may address molecular mechanisms, drug efficacy, safety, metabolism, therapeutic response, and interactions between medicines.

The supplied profile does not identify specific publication titles, experimental models, molecular targets, compounds, therapeutic areas, or clinical outcomes. Therefore, specific technical contributions are not attributed to the researcher beyond the documented subject classification. A detailed assessment of individual contributions would require review of the researcher’s publications and associated bibliographic records.

  • Research activity within the field of pharmacology.
  • Contribution to the indexed biomedical literature through a reported record of 86 documents.
  • Documented citation activity of 2,110 citations within the supplied profile.
  • A reported h-index of 25 as a measure of citation distribution within the indexed record.

These indicators describe scholarly output and visibility but do not by themselves establish the novelty, methodological quality, clinical relevance, or translational significance of individual studies.

Publications

The supplied research profile reports 86 documents and 2,110 citations. It does not provide a complete publication list, individual publication titles, journal information, publication dates, authorship details, or DOI identifiers for the researcher’s works. Consequently, no specific publication metadata are inferred in this article. For authoritative publication-level information, the researcher’s Scopus author record should be consulted directly. Database coverage, author disambiguation, citation counts, and document totals may change as indexing systems are updated.

Research Impact

The supplied profile reports 2,110 citations across 86 documents and an h-index of 25. These figures indicate that the indexed research record has received substantial citation activity within the reported database profile. Citation counts can provide evidence of scholarly visibility, although they do not by themselves measure research quality, reproducibility, clinical importance, or societal impact.

In pharmacology, research impact may arise through advances in understanding drug mechanisms, identification of biological targets, evaluation of therapeutic efficacy, characterization of safety profiles, or contributions to translational and clinical research. [1][2][3] The significance of a particular contribution therefore depends on the scientific question addressed, methodological rigor, reproducibility, and subsequent use of the findings.

For this profile, the available evidence supports a quantitative description of research impact based on document and citation counts and the reported h-index. Determining broader scientific or clinical impact would require additional evidence, such as highly cited publications, clinical translation, patents, guidelines, collaborations, or documented changes in research or healthcare practice.

Award Suitability

The Best Researcher Award profile is thematically aligned with Mohammad SEYEDABADI’s documented research specialization in pharmacology and the supplied record of scholarly output. The profile reports 86 documents, 2,110 citations, and an h-index of 25, providing several quantitative indicators that may be relevant when evaluating research activity and scholarly visibility.

The researcher is affiliated with Mazandaran University of Medical Sciences and is identified through Scopus Author ID 24460920400 and ORCID 0000-0003-0044-8270. These persistent identifiers provide mechanisms for distinguishing the researcher’s scholarly record and supporting bibliographic verification. On the basis of the supplied information, the profile provides a clear research-area match and a documented scholarly record that can support consideration for an award recognizing research activity. A formal award decision should additionally consider the official eligibility requirements, originality of research, methodological quality, peer-reviewed contributions, field-specific significance, and any qualitative criteria established by the World Science Awards.

Conclusion

Mohammad SEYEDABADI is identified in the supplied academic profile as a pharmacology researcher affiliated with Mazandaran University of Medical Sciences in Iran. The reported research record includes 86 documents, 2,110 citations, and an h-index of 25. These indicators provide a quantitative representation of the researcher’s indexed scholarly activity and citation visibility.

Pharmacology is an established biomedical field with direct relevance to drug mechanisms, therapeutic development, safety assessment, and clinical science. [1][2] The documented research specialization and bibliometric record provide a reasonable academic basis for an award profile focused on research achievement, while a comprehensive assessment of scientific distinction should incorporate publication-level evidence and qualitative evaluation in accordance with the applicable award criteria.

References

  1. Katzung, B. G., Vanderah, T. W. Basic & Clinical Pharmacology. McGraw Hill. This reference provides a general foundation for pharmacodynamics, pharmacokinetics, drug mechanisms, and therapeutic pharmacology.
  2. Brunton, L. L., Hilal-Dandan, R., Knollmann, B. C., eds. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. McGraw Hill. The text provides established principles concerning drug actions, therapeutic effects, mechanisms, and adverse reactions.
  3. Rang, H. P., Dale, M. M., Ritter, J. M., Flower, R. J., Henderson, G. Rang & Dale’s Pharmacology. Elsevier. This reference covers pharmacological mechanisms and the relationship between drugs and biological systems.
  4. Scopus. Scopus Author Profile: Mohammad SEYEDABADI, Author ID 24460920400. The supplied profile identifies the researcher and reports the bibliometric information used in this article.
  5. ORCID. ORCID Record: Mohammad SEYEDABADI, ORCID 0000-0003-0044-8270. The persistent identifier is supplied as the researcher’s ORCID record.

The DOI references above are provided where applicable to support established scholarly literature. The researcher-specific bibliometric values in this article are based on the supplied profile information and should be checked against the current database records for the latest values.

Shakir Siddiqui | Pharmacology | Research Excellence Award

Published on by World Science Awards

Research Excellence Award

Shakir Siddiqui
Saras College of Pharmacy
Shakir Siddiqui
Affiliation Saras College of Pharmacy
Country India
Scopus ID 60706630600
Documents 2
Citations 1
h-index 1
Subject Area Pharmacology
Event World Science Awards
ORCID 0009-0008-5328-8606

The Research Excellence Award recognizes scholarly contributions that demonstrate commitment to scientific research, academic development, and the advancement of knowledge within a defined discipline. Shakir Siddiqui, affiliated with Saras College of Pharmacy in India, has an emerging research profile in pharmacology supported by indexed scholarly publications and documented citation activity. The available bibliometric record provides an objective basis for describing his participation in the scientific literature.[1]

Abstract

Shakir Siddiqui is a researcher associated with Saras College of Pharmacy whose academic subject area is pharmacology. His available Scopus record comprises two indexed documents, one citation, and an h-index of one. These indicators represent an early-stage scholarly profile and demonstrate participation in formal scientific publication. Research in pharmacology contributes to the understanding of drugs, therapeutic mechanisms, safety, efficacy, and their applications in healthcare.[1][2]

Keywords

  • Pharmacology
  • Pharmaceutical Sciences
  • Drug Research
  • Clinical Pharmacology
  • Biomedical Research
  • Scientific Publications
  • Research Excellence
  • Health Sciences

Introduction

Pharmacology is a core biomedical discipline concerned with the study of medicines and their interactions with biological systems. It encompasses the mechanisms of drug action, pharmacokinetics, pharmacodynamics, therapeutic applications, adverse effects, and the development of evidence-based approaches to medication use. Research in this area supports the discovery and evaluation of treatments and contributes to improved healthcare practice.[2]

Research Profile

The available Scopus information identifies Shakir Siddiqui under the subject area of Pharmacology and records two indexed documents, one citation, and an h-index of one. These bibliometric measures indicate participation in scholarly research and provide a quantitative snapshot of the researcher’s current publication and citation activity.[1]

  • Affiliation: Saras College of Pharmacy.
  • Country: India.
  • Primary subject area: Pharmacology.
  • Scopus-indexed documents: 2.
  • Citations: 1.
  • h-index: 1.

Research Contributions

The researcher’s documented scholarly activity is situated within pharmacology and the broader pharmaceutical sciences. Research in these fields supports scientific understanding of therapeutic agents, biological responses, drug safety, and clinical applications. Contributions through peer-reviewed publication provide mechanisms for communicating findings to the wider scientific community and for supporting subsequent research.[2][3]

Publications

Shakir Siddiqui has two documents indexed in Scopus according to the supplied researcher profile. The indexed publication record represents scholarly dissemination within an internationally recognized bibliographic database. Continued publication and collaboration can provide opportunities for further development of research visibility and contribution to pharmacological literature.[1]

  • Indexed scholarly documents.
  • Pharmacology-related research.
  • Scientific communication through academic publications.
  • Participation in pharmaceutical and biomedical research.

Research Impact

Research impact can be considered through multiple dimensions, including publication quality, citation activity, methodological contribution, collaboration, and relevance to scientific or clinical practice. The current bibliometric profile records one citation and an h-index of one, providing measurable evidence of scholarly uptake within the indexed literature. These metrics should be interpreted in the context of publication volume and the researcher’s stage of academic development.[1]

Award Suitability

Based on the supplied academic information, Shakir Siddiqui demonstrates scholarly engagement in pharmacology through indexed research publications and documented citation activity. These characteristics may be considered as part of an award evaluation focused on research excellence. The World Science Awards may assess nominees using broader criteria such as research quality, originality, professional contribution, publication record, and potential impact; therefore, bibliometric indicators should be considered alongside qualitative evidence when evaluating award suitability.[1][4]

Conclusion

Shakir Siddiqui has established an emerging academic profile in pharmacology through participation in indexed scientific research. The available record of two Scopus documents, one citation, and an h-index of one provides a concise quantitative representation of his current scholarly activity. His affiliation with Saras College of Pharmacy places his research within the academic and pharmaceutical sciences environment, where continued investigation and publication can contribute to the development of evidence-based knowledge.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Shakir Siddiqui, Author ID 60706630600. Scopus.
    https://www.scopus.com/pages/authors/60706630600
  2. Brunton, L. L., Hilal-Dandan, R., & Knollmann, B. C. (eds.). Goodman & Gilman’s The Pharmacological Basis of Therapeutics. McGraw Hill.
    DOI: https://doi.org/10.1036/9781259588331
  3. Katzung, B. G., Vanderah, T. W. Basic & Clinical Pharmacology. McGraw Hill.
    DOI: https://doi.org/10.1036/9781260463325
  4. World Science Awards. (n.d.). Official Award Information.
    https://worldscienceawards.com/

Vibhu Sahani | Pharmacology | Lifetime Achievement Award

Published on by World Science Awards

Lifetime Achievement Award

Vibhu Sahani
LLRM Medical College, Meerut
Vibhu Sahani
Affiliation LLRM Medical College, Meerut
Country India
Scopus ID 59031594100
Documents 7
Citations 8
h-index 1
Subject Area Pharmacology
Event World Science Awards

The Lifetime Achievement Award recognizes sustained academic service, scholarly engagement, and professional contributions within a scientific discipline. Vibhu Sahani of LLRM Medical College, Meerut has contributed to the field of pharmacology through research, scholarly publication, and academic activities. The available bibliometric information indicates participation in peer-reviewed scientific communication and ongoing involvement in pharmacological research.[1]

Abstract

Vibhu Sahani is an academic associated with LLRM Medical College, Meerut, India, whose scholarly work is focused on pharmacology. His published research contributes to the understanding of pharmacological science and supports continued advancement in medical research. Available bibliometric indicators, including indexed publications and citations, reflect participation in the international scientific literature and ongoing academic engagement.[1][2]

Keywords

  • Pharmacology
  • Drug Research
  • Medical Science
  • Clinical Pharmacology
  • Biomedical Research
  • Scientific Publications
  • Research Impact
  • World Science Awards

Introduction

Pharmacology is a multidisciplinary scientific field dedicated to understanding the mechanisms, therapeutic applications, efficacy, and safety of medicinal compounds. Research in pharmacology contributes significantly to disease prevention, treatment innovation, and evidence-based healthcare. Academic researchers working in this discipline support advances through laboratory investigations, clinical studies, and scientific publication.[3]

Research Profile

Based on the available Scopus data, Vibhu Sahani has authored seven indexed documents, received eight citations, and holds an h-index of one. These bibliometric indicators demonstrate participation in scholarly research and publication within pharmacology while contributing to the scientific literature through peer-reviewed academic work.[1]

  • Affiliation with LLRM Medical College, Meerut.
  • Primary research area: Pharmacology.
  • Indexed scientific publications: 7.
  • Total citations: 8.
  • Scopus h-index: 1.

Research Contributions

The available publication record indicates contributions to pharmacological investigations and medical science. Research activities in this field support the understanding of therapeutic interventions, drug action, patient care, and evidence-based medicine. Such scholarly contributions form an important part of continued scientific development in healthcare disciplines.[2][3]

Publications

The researcher’s publication portfolio includes peer-reviewed scientific articles indexed within international scholarly databases. These publications demonstrate participation in academic research and dissemination of scientific findings relevant to pharmacology and associated biomedical disciplines.[1]

  • Peer-reviewed journal publications.
  • Pharmacological and biomedical research.
  • Scientific collaboration and academic dissemination.
  • Indexed scholarly contributions.

Research Impact

Research impact is commonly evaluated through publication output, citation performance, scholarly visibility, and contribution to scientific knowledge. The available metrics indicate that Vibhu Sahani has established an indexed research presence in pharmacology. These bibliometric indicators provide objective evidence of participation in scholarly communication while supporting continued academic development.[1]

Award Suitability

Based on the information provided, Vibhu Sahani demonstrates academic engagement through research publication, institutional affiliation, and contributions to pharmacology. Consideration for recognition within the World Science Awards may acknowledge sustained scholarly participation and professional service. Final award decisions should be based on the complete evaluation criteria established by the organizing committee, including academic achievements, research quality, professional experience, and broader scientific contributions.[1][2]

Conclusion

Vibhu Sahani has contributed to pharmacological research through scholarly publication and academic engagement at LLRM Medical College, Meerut. His indexed research record reflects participation in scientific communication and supports ongoing advancement within the biomedical sciences. The documented academic profile provides an objective overview of research activity relevant to professional recognition in the scientific community.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Vibhu Sahani, Author ID 59031594100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59031594100
  2. World Science Awards. (n.d.). Recognition of scientific excellence through international academic awards.
    https://worldscienceawards.com/
  3. Goodman & Gilman’s. The Pharmacological Basis of Therapeutics.
  4. Nature Reviews Drug Discovery. Drug discovery and pharmacological innovation.
    DOI: https://doi.org/10.1038/nrd.2017.232

Ved Pal | Pharmacology | Innovative Research Award

Published on by World Science Awards

Innovative Research Award

Ved Pal
Affiliation ISF College of Pharmacy, Moga, Punjab
Country India
Scopus ID 59895257200
Documents 3
Citations 5
h-index 1
Subject Area Pharmacology
Event World Science Awards
ORCID 0000-0003-3523-1469

Ved Pal
ISF College of Pharmacy, Moga, Punjab, India

The Innovative Research Award recognizes researchers whose scholarly activities demonstrate sustained commitment to scientific advancement, innovation, and academic excellence. VED PAL, affiliated with ISF College of Pharmacy, Moga, Punjab, has established an academic profile in the field of pharmacology through research contributions, professional engagement, and participation in internationally recognized scholarly platforms.[1]

Abstract

VED PAL is an academic researcher associated with ISF College of Pharmacy, Moga, Punjab, India. His scholarly interests are centered on pharmacology, an interdisciplinary field that integrates pharmaceutical sciences, biomedical research, and therapeutic innovation. His academic profile reflects ongoing engagement with scientific publication, research dissemination, and professional development within the pharmaceutical sciences.[1][2]

Keywords

Pharmacology, Pharmaceutical Sciences, Drug Research, Biomedical Science, Therapeutics, Academic Research, Scientific Publications, Innovation, World Science Awards, Healthcare Research.

Introduction

Pharmacology remains one of the most significant scientific disciplines supporting healthcare innovation through the study of medicines, therapeutic mechanisms, and biological responses. Researchers working in this field contribute toward improving evidence-based healthcare, advancing pharmaceutical technologies, and supporting interdisciplinary scientific collaboration. Academic recognition programs acknowledge these contributions by evaluating research quality, scholarly productivity, and scientific impact using internationally recognized academic indicators.[2][3]

Research Profile

VED PAL is affiliated with ISF College of Pharmacy in Punjab, India, where his academic interests align with pharmacological research and pharmaceutical sciences. His scholarly identity is represented through internationally recognized researcher identifiers, including a Scopus Author ID and an ORCID profile, supporting transparency in research attribution and academic visibility.[1][4]

Research Contributions

Research activities in pharmacology typically involve investigations related to drug discovery, therapeutic evaluation, pharmacodynamics, pharmacokinetics, toxicology, and clinical relevance. Through academic participation and publication activities, VED PAL contributes to the broader scientific dialogue supporting pharmaceutical research and evidence-driven healthcare. Such contributions encourage collaboration between academic institutions and the scientific community while promoting responsible research practices.[2][5]

Publications

The researcher’s scholarly output is indexed through the Scopus author profile associated with Author ID 59895257200. Publication records, citation data, and bibliographic information are maintained through recognized academic indexing systems, allowing researchers and institutions to monitor scientific productivity and collaboration.[1]

Research Impact

Research impact extends beyond publication volume and includes scientific influence, collaboration, knowledge dissemination, and practical application of research findings. International researcher identifiers such as ORCID and Scopus improve research discoverability, strengthen scholarly communication, and facilitate accurate attribution across academic databases. These systems support transparent evaluation of academic achievements within the global research ecosystem.[1][4]

Award Suitability

The Innovative Research Award recognizes researchers demonstrating commitment to scholarly excellence, ethical research practices, scientific innovation, and meaningful contributions within their discipline. Based on the available academic identifiers, institutional affiliation, and specialization in pharmacology, VED PAL represents a researcher whose profile aligns with the objectives of recognizing ongoing scientific engagement and academic development through the World Science Awards.[5]

Conclusion

VED PAL’s academic profile reflects continued participation in pharmaceutical research and international scholarly communication. Through institutional affiliation, recognized researcher identifiers, and engagement with pharmacological sciences, the profile illustrates a commitment to research integrity, scientific advancement, and professional development. Recognition through the Innovative Research Award highlights the importance of sustained contributions to contemporary scientific research while encouraging future innovation within the pharmaceutical sciences.[1][5]

References

  1. Elsevier. (n.d.). Scopus Author Details: VED PAL, Author ID 59895257200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59895257200
  2. Brunton, L. L., Hilal-Dandan, R., & Knollmann, B. C. (2023). Goodman & Gilman’s The Pharmacological Basis of Therapeutics.
    DOI: https://doi.org/10.1038/s41573-021-00234-4
  3. World Health Organization. (n.d.). Research for Health.
    https://www.who.int
  4. ORCID. (n.d.). ORCID Record: 0000-0003-3523-1469.
    https://orcid.org/0000-0003-3523-1469
  5. World Science Awards. (n.d.). Award Evaluation and Recognition Framework.
    https://worldscienceawards.com/

Liang Zhou | Clinical Pharmacology | Best Researcher Award

Published on by World Science Awards

Ms. Liang Zhou | Clinical Pharmacology | Best Researcher Award

Shanghai Henlius Biotech Inc., China

Ms. Liang Zhou is a distinguished clinical pharmacology professional with extensive experience in oncology drug development, pharmacokinetics, and translational research. She earned her Master’s degree in Drug Metabolism and Pharmacokinetics from the China Pharmaceutical University in 2008, which laid the foundation for her successful career in pharmaceutical sciences. Over the years, she has held progressive positions in leading global and Chinese organizations, including Associate Senior Scientist at Wuxi Apptec, Demo Chemist at Thermo Fisher Shanghai, Associate Director of Clinical Pharmacology at Mosim, and currently serves as the Senior Director of Clinical Pharmacology at Shanghai Henlius Biotech, Inc. since 2021. In these roles, she has contributed to more than 11 significant clinical trial programs across China, Australia, Japan, Europe, and the United States, with a strong focus on first-in-human (FIH) trials, PK/PD analysis, and oncology indications such as breast cancer, lymphoma, AML, NSCLC, gastric and pancreatic cancers, among others. Her research interests center on oncology drug development, dose exploration studies, biomarker integration, and regulatory science to accelerate access to novel therapies. With 23 academic documents, 91 citations, and an h-index of 4, Ms. Zhou demonstrates measurable scholarly impact, supported by her memberships in professional societies such as the Chinese Society of Clinical Oncology (CSCO). She has also enhanced her expertise through specialized training in GCP compliance, oncology drug development, and advanced pharmacometrics including R-language applications. Her skills encompass pharmacokinetic modeling, clinical trial design, regulatory submission, and team leadership, which collectively position her as a key figure in clinical pharmacology. Recognized for her contributions to cancer research and drug development, she continues to build a strong professional profile with the potential for international recognition. In conclusion, Ms. Liang Zhou’s blend of academic excellence, clinical research leadership, and commitment to advancing oncology therapeutics makes her a deserving candidate for prestigious awards and a driving force in global biomedical innovation.

Profile: Scopus

Featured Publications

Li, X., Zhang, Y., Wang, J., Chen, H., Zhou, L., Liu, M., … [et al.]. (2023). HLX22, an anti-HER-2 monoclonal antibody, in patients with advanced solid tumors overexpressing human epidermal growth factor receptor 2: An open-label, dose-escalation, phase 1 trial.(5)

Ticuta Negreanu-Pirjol | Pharmacology | Best Researcher Award

Published on by World Science Awards

Prof. Dr. Ticuta Negreanu-Pirjol | Pharmacology | Best Researcher Award

Head of General and Inorganic Chemistry Discipline at Ovidius University of Constanta, Faculty of Pharmacy, Pharmaceuticals Sciences Department No. 1, Romania

Ticuta Negreanu-Pirjol, a Full Professor at the University Ovidius of Constanta, Romania, is a distinguished academic and researcher specializing in General and Inorganic Chemistry. With decades of experience in teaching, research, and administrative roles, she has played a pivotal role in shaping the academic and research landscape in Romania. Her extensive teaching portfolio includes managing courses across Pharmacy, Pharmacy Assistance, Medical Cosmetics, and Parapharmaceuticals, showcasing her versatility and dedication to education. Ticuta has also significantly contributed to the pharmaceutical industry as a Head Pharmacist. Her active involvement in professional training programs reflects her commitment to lifelong learning and advancement in her field.

Professional Profile

Education

Ticuta’s academic journey reflects a consistent pursuit of excellence. She earned her Ph.D. in Chemistry from the Polytechnic University of Bucharest in 2005, specializing in Inorganic and Coordinative Chemistry. Prior to that, she completed a Bachelor’s in Pharmacy at the Carol Davila University of Medicine and Pharmacy and a Chemical Engineering degree at the Gheorghe Asachi Polytechnic Institute. Ticuta further advanced her expertise through a Master’s in Health Services Management from the University Ovidius of Constanta. These achievements underline her interdisciplinary expertise, integrating pharmacy, chemistry, and management to excel in both academia and industry.

Professional Experience

Ticuta Negreanu-Pirjol has a robust professional background spanning over three decades. She began her career as a Chemical Engineer before transitioning to academia, where she served as a Lecturer, Associate Professor, and later as a Full Professor at the University Ovidius of Constanta. In these roles, she has headed multiple disciplines, organized courses, and developed curricula in General and Inorganic Chemistry and related fields. Additionally, Ticuta held the position of Head Pharmacist at Eurosantal Pharmacy, bridging the gap between academic research and practical applications. Her administrative expertise is evident in her leadership roles within the university, contributing to the development of academic programs and fostering research initiatives.

Research Interests

Ticuta’s research interests lie at the intersection of inorganic chemistry, pharmaceutical sciences, and biological processes. Her doctoral work focused on the complex combinations of transition metals in biological systems, a topic with significant implications in medical and pharmaceutical research. She has also explored parapharmaceuticals, cosmetic products, and technical-medical products, demonstrating a keen interest in applied chemistry. Through her work, Ticuta aims to contribute to advancements in healthcare and product innovation, ensuring that her research addresses real-world challenges.

Research Skills

Ticuta possesses a broad range of research skills, including expertise in chemical synthesis, analysis, and characterization. She is proficient in utilizing advanced tools and methodologies in inorganic and coordinative chemistry. Her skills extend to data analysis, academic writing, and project management, which are critical for successful research outcomes. Furthermore, her active participation in Web of Science training programs and research ethics courses highlights her commitment to staying updated with the latest trends and best practices in research.

Awards and Honors

Throughout her career, Ticuta has been recognized for her contributions to academia and research. Her achievements include a professional certification as a pharmacist and numerous certifications in advanced research methodologies. She has received accolades for her dedication to teaching and her ability to inspire the next generation of scientists. Her involvement in national and international training programs further highlights her standing as a respected figure in the academic and scientific community.

Conclusion

Ticuta Negreanu-Pirjol is a distinguished academic whose contributions to education, research, and professional development have left a lasting impact. Her extensive academic qualifications, diverse professional experience, and dedication to research make her a strong candidate for any prestigious award. She exemplifies the qualities of a researcher committed to innovation and excellence, with a focus on addressing contemporary challenges in science and healthcare. Her career is a testament to her passion for lifelong learning, mentorship, and advancing knowledge in her field.

Publication Top Notes

  1. Title: Aquatic plants used for heavy metals phytoaccumulation and phytoremediation potential: A review
    Authors: Negreanu-Pirjol, B.-S., Popovidu, D.R., Negreanu-Pirjol, T.
    Year: 2024
    Citations: 0
  2. Title: The Chemical Profile, Antioxidant, and Anti-Lipid Droplet Activity of Fluid Extracts from Romanian Cultivars of Haskap Berries, Bitter Cherries, and Red Grape Pomace for the Management of Liver Steatosis
    Authors: Craciunescu, O., Seciu-Grama, A.-M., Mihai, E., Ranca, A., Negreanu-Pirjol, B.-S.
    Year: 2023
    Citations: 4
  3. Title: Natural Bio-Compounds from Ganoderma lucidum and Their Beneficial Biological Actions for Anticancer Application: A Review
    Authors: Cadar, E., Negreanu-Pirjol, T., Pascale, C., Tomescu, C.L., Ionescu, A.-M.
    Year: 2023
    Citations: 11
  4. Title: Biocompounds from Green Algae of Romanian Black Sea Coast as Potential Nutraceuticals
    Authors: Cadar, E., Negreanu-Pirjol, T., Sirbu, R., Axente, E.R., Ionescu, A.-M.
    Year: 2023
    Citations: 6
  5. Title: Health Benefits of Antioxidant Bioactive Compounds in the Fruits and Leaves of Lonicera caerulea L. and Aronia melanocarpa (Michx.) Elliot
    Authors: Negreanu-Pirjol, B.-S., Oprea, O.C., Negreanu-Pirjol, T., Cosma, M., Popoviciu, D.R.
    Year: 2023
    Citations: 28
  6. Title: In Vitro Hypoglycemic Potential, Antioxidant and Prebiotic Activity after Simulated Digestion of Combined Blueberry Pomace and Chia Seed Extracts
    Authors: Mihai, E., Negreanu-Pirjol, B.-S., Craciunescu, O., Ghenea, A.-M., Negreanu-Pirjol, T.
    Year: 2023
    Citations: 3
  7. Title: Xanthophyll pigments dietary supplements administration and retinal health in the context of increasing life expectancy trend
    Authors: Jurja, S., Negreanu-Pirjol, T., Vasile, M., Coviltir, V., Negreanu-Pirjol, B.-S.
    Year: 2023
    Citations: 0
  8. Title: Preliminary Data Regarding Bioactive Compounds and Total Antioxidant Capacity of Some Fluid Extracts of Lonicera caerulea L. Berries
    Authors: Negreanu-Pirjol, B.-S., Negreanu-Pirjol, T., Popoviciu, D.R., Motelica, L., Vasile, M.
    Year: 2023
    Citations: 2
  9. Title: Marine Bioactive Compounds Derived from Macroalgae as New Potential Players in Drug Delivery Systems: A Review
    Authors: Negreanu-Pirjol, B.-S., Negreanu-Pirjol, T., Popoviciu, D.R., Anton, R.-E., Prelipcean, A.-M.
    Year: 2022
    Citations: 19
  10. Title: Marine and Agro-Industrial By-Products Valorization Intended for Topical Formulations in Wound Healing Applications
    Authors: Prelipcean, A.-M., Iosageanu, A., Gaspar-Pintiliescu, A., Marin, M., D’Amora, U.
    Year: 2022
    Citations: 13

 

 

Moein Masjedi | Pharmacology | Best Researcher Award

Published on by World Science Awards

Moein Masjedi | Pharmacology | Best Researcher Award

Moein Masjedi, DarooSazan Sorena Exir Pharmaceutical Company, Iran.

Moein Masjedi is a dedicated researcher in the field of pharmacology, recognized for his innovative contributions to drug development and therapeutic strategies. With a strong academic background and a commitment to advancing scientific knowledge, he has published numerous influential papers that address critical challenges in the field. Awarded the Best Researcher Award for his outstanding research impact, Moein continues to inspire peers and students through his passion for improving health outcomes and enhancing patient care.

Profile:

Education

Moein Masjedi earned his Doctor of Pharmacy degree from Shiraz University of Medical Sciences in Shiraz, Fars, Iran, where he completed his thesis on the drug utilization evaluation of captopril in two coronary care units at Namazi Hospital, achieving a GPA of 15.64 out of 20. He then pursued a Ph.D. in Pharmaceutics at the same institution, focusing on the nose-to-brain delivery of Sumatriptan using chitosan nanoparticles and nanostructured lipid carriers (NLCs), and graduated with a GPA of 17.83 out of 20.

 

Skills 

Moein Masjedi possesses a diverse skill set that enhances his effectiveness as a researcher and collaborator. He excels in strong and collaborative communication, fostering teamwork and idea exchange. His creativity in problem-solving and critical thinking enables him to tackle complex challenges in pharmacology. Demonstrating leadership qualities, he effectively manages projects while prioritizing time management to meet deadlines. Additionally, he is skilled in structural scientific writing and proofreading, ensuring clarity and precision in his research publications. Beyond academia, Moein has a passion for art interpretation and enjoys swimming and yoga, which contribute to his overall well-being and work-life balance.

Areas of Interest:

Moein Masjedi’s research interests focus on innovative drug delivery systems and formulation design. He is particularly passionate about nanoparticulate drug delivery and the optimization of formulations for pulmonary, ocular, topical, and transdermal applications. His work includes designing novel drug delivery systems targeting specific sites such as the pulmonary system, colon, brain, and hair follicles. He explores the use of nanovesicles, lipid, and polymeric nanoparticles for both therapeutic and cosmetic applications. Additionally, Moein is interested in D-optimal optimization of aesthetic formulations and the development of stimuli-responsive or smart polymers for drug delivery. He employs Design of Experiments (DoE) methodologies to optimize formulations and is also engaged in the innovative 3D printing of pharmaceutical dosage forms, aiming to advance the field of pharmaceutics.

Publication Top Notes

  1. Masjedi, M., Izadi, Y., Montahaei, T., Mohammadi, R., Helforoush, M. A., & Rohani Rad, K. (2024). An illustrated review on herbal medicine used for the treatment of female infertility. European Journal of Obstetrics and Gynecology and Reproductive Biology, 0(0).
  2. Dahri, M., Beheshtizadeh, N., Seyedpour, N., Nakhostin-Ansari, A., Aghajani, F., Seyedpour, S., Masjedi, M., Farjadian, F., Maleki, R., & Adibkia, K. (2023). Biomaterial-based delivery platforms for transdermal immunotherapy. Biomedicine & Pharmacotherapy, 165, 115048.
  3. Rezaie, F., Farshbaf, M., Dahri, M., Masjedi, M., Maleki, R., Amini, F., Wirth, J., Moharamzadeh, K., Weber, F. E., & Tayebi, L. (2023). 3D printing of dental prostheses: Current and emerging applications. Journal of Composites Science, 7(2), 80.
  4. Masjedi, M., Montahaei, T., Sharafi, Z., & Jalali, A. (2022). Pulmonary vaccine delivery: An emerging strategy for vaccination and immunotherapy. Journal of Drug Delivery Science and Technology, 103184.
  5. Masjedi, M., & Solhjoo, A. (2022). Does trigonelline help skin tone? Molecular docking studies of trigonelline on the human tyrosinase, formulation, optimization and characterization of an emulgel containing Trigonella foenum‐graecum L. fenugreek standardized hydroalcoholic extract. Journal of Cosmetic Dermatology.
  6. Masjedi, M., & Namazi, S. (2020). Drug utilization evaluation (DUE) of captopril in two coronary care units (CCU) of Namazi Hospital, Shiraz, Iran.
  7. Masjedi, M., & Montahaei, T. (2020). An illustrated review on nonionic surfactant vesicles (niosomes) as an approach in modern drug delivery: Fabrication, characterization, pharmaceutical, and cosmetic applications. Journal of Drug Delivery Science and Technology, 102234.
  8. Masjedi, M., Azadi, A., Heidari, R., & Mohammadi-Samani, S. (2020). Brain targeted delivery of sumatriptan succinate loaded chitosan nanoparticles: Preparation, in vitro characterization, and (neuro-) pharmacokinetic evaluations. Journal of Drug Delivery Science and Technology, 102179.
  9. Ziaei, A., Davoodian, P., Dadvand, H., Safa, O., Hassanipour, S., Omidi, M., Masjedi, M., Mahmoudikia, F., Rafiee, B., & Fathalipour, M. (2020). Evaluation of the efficacy and safety of melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials, 21(1), 1-3.
  10. Masjedi, M., Azadi, A., Heidari, R., & Mohammadi‐Samani, S. (2020). Nose‐to‐brain delivery of sumatriptan‐loaded nanostructured lipid carriers: Preparation, optimization, characterization, and pharmacokinetic evaluation. Journal of Pharmacy and Pharmacology, 72(10), 1341-1351.

Sujatha Kuppusamy | Microbiology | Best Researcher Award

Published on by World Science Awards

Sujatha Kuppusamy | Microbiology | Best Researcher Award

Professor & Vice – Principal, Sri Ramachandra Institute of Higher Education and Research, India.

Dr. K. Sujatha Kuppusamy is a renowned Professor in the Department of Pharmaceutical Chemistry at Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (DU) in Chennai, India. With over 25 years of academic and research experience, she has significantly contributed to pharmaceutical sciences, particularly in drug formulation and quality assurance. Dr. Sujatha holds a Ph.D. from Sri Ramachandra University and has received multiple awards for her research, including gold medals for long-term service and recognition for her presentations at various conferences. Her research interests encompass drug delivery systems, quality by design (QbD) methodologies, and sustainable formulation development, addressing critical healthcare challenges. She is also recognized as an International Woman of the Year in 2022, highlighting her influence and commitment to advancing healthcare outcomes through her work in pharmaceuticals.

Profile:

Scopus Profile

ORCID

Education

Dr. K. Sujatha Kuppusamy’s educational journey is marked by exceptional achievements and a strong foundation in pharmaceutical sciences. She completed her Ph.D. at Sri Ramachandra University in January 2009, where her research was highly commended, reflecting her dedication and expertise in the field. Prior to her doctoral studies, she earned her Master of Pharmacy (M.Pharm) in Pharmaceutical Chemistry in March 1997 from The T.N. Dr. MGR Medical University, graduating with first-class honors. Dr. Sujatha’s academic credentials are further solidified by her Bachelor of Pharmacy (B.Pharm) degree, which she obtained in April 1994, also with first-class distinction from The T.N. Dr. MGR Medical University. This strong educational background not only showcases her commitment to academic excellence but also equips her with the knowledge and skills necessary to contribute significantly to research and teaching in the pharmaceutical domain.

Professional Experience

Dr. K. Sujatha Kuppusamy has a robust academic and professional background that spans over 25 years in the field of pharmaceutical sciences. She began her career as an Assistant Professor at Kamalakshi Pandurangan College of Pharmacy in 1997 before transitioning to Sri Ramachandra College of Pharmacy, where she held various positions, including Lecturer and Assistant Professor. In 2009, she was promoted to Professor in the Faculty of Pharmacy at Sri Ramachandra University, where she continues to contribute significantly to both teaching and research. Throughout her career, Dr. Sujatha has been actively involved in guiding students in their research projects, fostering an environment of academic excellence. Her leadership extends to her role as the Chairperson of the Institutional Animal Ethics Committee, where she ensures compliance with ethical standards in research. Dr. Sujatha’s extensive experience has not only enriched the academic community but has also facilitated collaborative research efforts that address pressing healthcare challenges. Her commitment to education and research excellence has earned her respect and recognition among her peers and students alike.

Research Interests

Dr. K. Sujatha Kuppusamy’s research interests encompass a broad spectrum of topics within pharmaceutical sciences, with a particular focus on drug delivery systems and quality assurance methodologies. She is deeply engaged in the concept of Quality by Design (QbD), aiming to enhance the efficiency and reliability of pharmaceutical formulations. Her work often involves developing innovative drug delivery systems, such as sustained release formulations and novel encapsulation techniques, to improve therapeutic outcomes. Additionally, Dr. Sujatha is dedicated to exploring natural polymers and their applications in drug formulation, particularly for antidiabetic and other therapeutic agents. She also investigates the integration of traditional medicinal practices with modern pharmaceutical approaches, striving to bridge the gap between conventional and alternative therapies. Through her research, she seeks to address critical healthcare challenges and contribute to the advancement of safer, more effective pharmaceuticals, ultimately aiming to improve patient care and treatment options.

Award and Recognition

Dr. K. Sujatha Kuppusamy has received numerous awards and recognitions throughout her illustrious career, highlighting her commitment and contributions to the field of pharmaceutical sciences. She was awarded a gold medal and a certificate for her ten years of continuous service at Sri Ramachandra University, followed by another gold medal for her two decades of dedication to the institution. Her research excellence has been recognized multiple times; she guided a research paper that won the Best Presentation award at the Indo-American Pharmaceutical Regulatory Symposium and secured a second prize in the National Conference on Recent Advances in Pharmaceutical Sciences. Additionally, she has received several certificates of appreciation for her best research papers, showcasing her impactful work. Dr. Sujatha has also been honored with multiple awards for her poster presentations at national seminars, including first prize for her research on Indian traditional medicines for managing diabetes. Furthermore, she serves as the Chairperson of the Institutional Animal Ethics Committee, reflecting her leadership in ethical research practices. Her accolades culminated in being named an International Woman of the Year in 2022, recognizing her significant impact in her field and inspiring future generations of researchers.

 

Publication Top Notes

      1. QbD-Based Stability-Indicating RP-HPLC Method Development and Validation for the Estimation of Favipiravir—An Eco-Friendly Approach
        Authors: Siri Chandana, M., Sujatha, K., Ajitha, A., Narendra, P., Sonia, K.
        Year: 2024
        Citation: Journal of AOAC International, 107(3), pp. 377–386. 🧪🌱
      2. An Overview of Pharmacological Activities and Beneficial Effects of 3-Hydroxyflavone
        Authors: Ayyanna, C., Kuppusamy, S., Kumar, P.P.
        Year: 2024
        Citation: Macromolecular Symposia, 413(2), 2300078. 📚💊
      3. Analytical Quality by Design-Assisted HPLC Method for Quantification of Canagliflozin and Stability Studies
        Authors: Azhakesan, A., Kuppusamy, S.
        Year: 2023
        Citation: ACS Omega, 8(8), pp. 7407–7414. 🔍📈
      4. Development and Validation of UFLC-MS/MS Analytical Method for the Simultaneous Quantification of Antibiotic Residues in Surface Water, Groundwater, and Pharmaceutical Waste Water Samples from South India
        Authors: Kamatham, S., Seeralan, M., Sekar, U., Kuppusamy, S.
        Year: 2023
        Citation: ACS Omega. 🌊💧
      5. QbD-Based Development and Validation of Novel Stability-Indicating Method for the Assay and Dissolution of Garenoxacin in Garenoxacin Tablets
        Authors: Azhakesan, A., Kuppusamy, S.
        Year: 2022
        Citation: Journal of AOAC International, 105(2), pp. 370–378. 📦💊
      6. Canagliflozin: A review with specific focus on analytical methods in biological matrices and pharmaceuticals
        Authors: Azhakesan, A., Kuppusamy, S.
        Year: 2022
        Citation: Reviews in Analytical Chemistry, 41(1), pp. 287–300. 🧬📖
      7. Formulation and Evaluation of Miglitol Matrix Tablets by Using Hibiscus Rosa Sinensis Leaves Mucilage
        Authors: Deepika, B., Sujatha, K., Thanga Thirupathi, A., Chamundeeswari, D.
        Year: 2021
        Citation: Research Journal of Pharmacy and Technology, 14(1), pp. 245–248. 🌺💊
      8. Bioanalytical Method Development and Validation for Simultaneous Estimation of Nitazoxanide and Ofloxacin in Human Plasma by RP-HPLC
        Authors: Ajitha, A., Abbulu, K., Sujatha, K., Sireesha, P.
        Year: 2020
        Citation: Indian Drugs, 57(10), pp. 47–57. 💉🔬
      9. Bioanalytical Method Development and Validation of Garenoxacin Mesylate in Human Plasma by RP-HPLC
        Authors: Ajitha, A., Sujatha, K., Abbulu, K.
        Year: 2019
        Citation: International Journal of Research in Pharmaceutical Sciences, 10(2), pp. 1314–1320. 🧪🩸
      10. The Identification of Bioactive Compounds from Turbinaria Ornata (Turner) J. Agaradh and Computational Studies
        Authors: Deepa, S., Sujatha, K., Velmurugan, D.
        Year: 2019
        Citation: Pharmacognosy Journal, 11(5), pp. 873–883. 🍃🔍

Mary Nyakato | social sciences | Best Researcher Award

Published on by World Science Awards

Mary Nyakato | social sciences | Best Researcher Award

Doctoral student, Makerere University, Uganda

Mary Nyakato is a dedicated Family and Child Psychologist currently pursuing her PhD in Neuropsychology. With over a decade of professional experience, she has made significant contributions to the field of child psychology through her research, clinical practice, and community engagement. Mary’s work focuses on understanding and enhancing children’s psychological development, particularly in structured settings.

Profile:

Scopus Profile

Education

Mary Nyakato’s educational journey reflects her commitment to advancing her expertise in psychology and neuropsychology. She earned her Master’s degree in Psychology from the University of Chester in the United Kingdom (2015-2016), where she gained a solid foundation in theoretical and practical aspects of psychological practice. Prior to this, Mary completed her Bachelor’s degree at Makerere University in Kampala, Uganda, from 2007 to 2010, establishing her initial grounding in the field. Currently, she is pursuing her PhD in Neuropsychology at Makerere University, focusing on critical research that examines neurodevelopmental outcomes in children. This combination of international education and ongoing doctoral studies enables Mary to integrate global perspectives with local insights, enhancing her research and clinical practice. Her academic background underscores her dedication to understanding and improving children’s psychological well-being through rigorous education and research initiatives.

Professional Experience

Mary Nyakato has over a decade of experience as a Family and Child Psychologist, specializing in psychological evaluations and therapeutic interventions. Currently serving at the Kampala City Council Authority, she conducts needs assessments for children and adolescents, offering psychotherapy and psychoeducation tailored to their unique needs. Previously, she held the position of Neuropsychological Tester and Child Psychologist at MUJHU-Care LTD, where she led a team in administering various neurodevelopmental assessments. Her leadership extended to providing training for staff across multiple research sites in Africa, ensuring high standards in neuropsychological testing and quality control. Mary’s hands-on experience is complemented by her roles in significant research studies, where she has acted as a co-investigator and psychologist. Her extensive background in both clinical practice and research equips her to make substantial contributions to the field of child psychology and neurodevelopment.

Research Interests

Mary Nyakato’s research interests are centered on understanding children’s psychological development, particularly through the lens of neuropsychology. She focuses on the neurodevelopmental outcomes of children affected by early life adversities, such as severe malaria and maternal health issues. Mary is particularly interested in exploring how cognitive and emotional development can be influenced by various socio-economic and health factors. Her work aims to bridge the gap between clinical practice and research, using evidence-based approaches to inform interventions that promote psychological well-being in children. Additionally, she is passionate about developing standardized neuropsychological assessments that can be effectively implemented in resource-limited settings, ensuring that children receive appropriate evaluations and support. By investigating the interplay between neurological factors and psychological health, Mary seeks to contribute to the broader understanding of childhood development and improve outcomes for vulnerable populations in Uganda and beyond.

Award and Recognition

Mary Nyakato has received several prestigious awards and recognitions that highlight her significant contributions to the field of psychology. In 2023, she was awarded a research grant from the Makerere University Research and Innovations Fund (MAKRIF) for her project focused on the neurodevelopmental outcomes of early life infections among Ugandan children. This recognition underscores her commitment to advancing understanding in neuropsychology and child development. Additionally, Mary was honored with the Commonwealth Scholarship for her Master’s degree in Family and Child Psychology, reflecting her academic excellence and potential for impactful research. Her involvement with the Uganda Christian Psychologists’ Society further showcases her dedication to professional development and community engagement. These accolades not only validate her expertise but also emphasize her ongoing efforts to enhance children’s mental health and well-being through research, training, and clinical practice.

 

Publication Top Notes

  • Title: Use of the Creating Opportunities for Parent Empowerment Program to Decrease Mental Health Problems in Ugandan Children Surviving Severe Malaria
    Authors: Bangirana, P., Birabwa, A., Nyakato, M. et al.
    Year: 2021
    Citation: Malaria Journal, 20, 267. https://doi.org/10.1186/s12936-021-03795-y
    Emojis: 🌍🧠👶
  • Title: Neurodevelopmental Effects of Ante-partum and Post-partum Antiretroviral Exposure in HIV-Exposed and Uninfected Children Versus HIV-Unexposed and Uninfected Children in Uganda and Malawi: A Prospective Cohort Study
    Authors: Boivin, M., Maliwichi-Senganimalunje, L., Ogwang, W.L., Kawalazira, R., Sikorskii, A., Familiar-Lopez, I., Kuteesa, A., Nyakato, M., Mutebe, A., Namukooli, J.L., Mallewa, M., Ruiseñor-Escudero, H., Aizire, J., Taha, E.T., & Fowler, M.G.
    Year: 2019
    Citation: The Lancet HIV.
    Emojis: 💊👶🌈
  • Title: Building Capacity in Neurodevelopment Assessment of Children in Sub-Saharan Africa: A Quality Assurance Model to Implement Standardized Neurodevelopment Testing
    Authors: Ruiseñor-Escudero, H., Familiar, I., Nyakato, M., Kutessa, A., Namukooli, J., Ssesanga, T., Joyce, C., Laughton, B., Grab, J., Chernoff, M., Vhembo, T., Fairlie, L., Kamthunzi, P., Boivin, M & the IMPAACT P1104s Team
    Year: 2018
    Citation: Child Neuropsychology, Journal on Normal and Abnormal Development in Childhood and Adolescence, 1-16.
    Emojis: 📚🧠🌍
  • Title: Neurodevelopment of Ugandan and Malawian PROMISE Exposed and Unexposed Uninfected Children at 12 and 24 Months of Age
    Authors: Boivin, M.J., Malawichi-Senganimalunje, L., Nyakato, M., Sikorski, A., Ogwang, L.W., Kawalazira, R., Mallewa, M., Familiar-Lopez, I., Horacio, E., Aizire, J., Taha, T., & Fowler, M.G.
    Year: 2016
    Citation: Conference paper presented at the International AIDS Society Meeting, Durban, RSA.
    Emojis: 🎓👶🇿🇦